Search bioRxivSearch

Biology subjects

Cunningham, F.

Publications and source records attributed to Cunningham, F..

2 recordsLinked to original sources

VEP-G2P: A Tool for Efficient, Flexible and Scalable Diagnostic Filtering of Genomic Variants

PurposeWe aimed to develop an efficient, flexible, scalable and evidence-based approach to sequence-based diagnostic analysis/re-analysis of conditions with very large numbers of different causative genes. We then wished to define the expected rate of plausibly causative variants coming through strict filtering in control in comparison to disease populations to quantify background diagnostic \"noise\".\n\nMethodsWe developed G2P (www.ebi.ac.uk/gene2phenotype) as an online system to facilitate the development, validation, curation and distribution of large-scale, evidence-based datasets for use in diagnostic variant filtering. Each locus-genotype-mechanism-disease-evidence thread (LGMDET) associates an allelic requirement and a mutational consequence at a defined locus with a disease entity and a confidence level and evidence links. We then developed an extension to Ensembl Variant Effect Predictor (VEP), VEP-G2P, which can filter based on G2P other widely used gene panel curation systems. We compared the output of disease-associated and control whole exome sequence (WES) using Developmental Disorders G2P (G2PDD; 2044 LGMDETs) and constitutional cancer predisposition G2P (G2PCancer; 128 LGMDETs).\n\nResultsWe have shown a sensitivity/precision of 97.3%/33% and 81.6%/22.7% for causative de novo and inherited variants respectively using VEP-G2PDD in DDD study probands WES. Many of the apparently diagnostic genotypes \"missed\" are likely false-positive reports with lower minor allele frequencies and more severe predicted consequences being diagnostically-discriminative features.\n\nConclusionCase:control comparisons using VEP-G2PDD established an observed:expected ratio of 1:30,000 plausibly causative variants in proband WES to ~1:40,000 reportable but presumed-benign variants in controls. At least half the filtered variants in probands represent background \"noise\". Supporting phenotypic evidence is, therefore, necessary in genetically-heterogeneous disorders. G2P and VEP-G2P provides a practical approach to optimize disease-specific filtering parameters in diagnostic genetic research.

genetics

A Standardized Framework For Representation Of Ancestry Data In Genomics Studies

BackgroundThe accurate description of ancestry is essential to interpret and integrate human genomics data, and to ensure that advances in the field of genomics benefit individuals from all ancestral backgrounds. However, there are no established guidelines for the consistent, unambiguous and standardized description of ancestry. To fill this gap, we provide a framework, designed for the representation of ancestry in GWAS data, but with wider application to studies and resources involving human subjects.\n\nResultHere we describe our framework and its application to the representation of ancestry data in a widely-used publically available genomics resource, the NHGRI-EBI GWAS Catalog. We present the first analyses of GWAS data using our ancestry categories, demonstrating the validity of the framework to facilitate the tracking of ancestry in big data sets. We exhibit the broader relevance and integration potential of our method by its usage to describe the well-established HapMap and 1000 Genomes reference populations. Finally, to encourage adoption, we outline recommendations for authors to implement when describing samples.\n\nConclusionsWhile the known bias towards inclusion of European ancestry individuals in GWA studies persists, African and Hispanic or Latin American ancestry populations contribute a disproportionately high number of associations, suggesting that analyses including these groups may be more effective at identifying new associations. We believe the widespread adoption of our framework will increase standardization of ancestry data, thus enabling improved analysis, interpretation and integration of human genomics data and furthering our understanding of disease.

genetics